Market Research Logo

Applied Genetic Technologies Corporation - Product Pipeline Review - 2015

Applied Genetic Technologies Corporation - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Applied Genetic Technologies Corporation - Product Pipeline Review - 2015’, provides an overview of the Applied Genetic Technologies Corporation’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Applied Genetic Technologies Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Applied Genetic Technologies Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Applied Genetic Technologies Corporation’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Applied Genetic Technologies Corporation’s pipeline products
Reasons to buy
  • Evaluate Applied Genetic Technologies Corporation’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Applied Genetic Technologies Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Applied Genetic Technologies Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Applied Genetic Technologies Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Applied Genetic Technologies Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Applied Genetic Technologies Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Applied Genetic Technologies Corporation Snapshot
Applied Genetic Technologies Corporation Overview
Key Information
Key Facts
Applied Genetic Technologies Corporation - Research and Development Overview
Key Therapeutic Areas
Applied Genetic Technologies Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Applied Genetic Technologies Corporation - Pipeline Products Glance
Applied Genetic Technologies Corporation - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Applied Genetic Technologies Corporation - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Applied Genetic Technologies Corporation - Drug Profiles
Gene Therapy to Activate Alpha-1 Antitrypsin for Alpha-Antitrypsin Deficiency
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for Achromatopsia
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for X-linked retinoschisis
Product Description
Mechanism of Action
R&D Progress
rAAV2-CB-hAAT
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for Ophthalmology
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for Wet Age-related Macular Degeneration
Product Description
Mechanism of Action
R&D Progress
Gene Therapy to Activate Cone Photoreceptor cGMP-Gated Channel for Achromatopsia
Product Description
Mechanism of Action
R&D Progress
Gene Therapy to Activate RPGR for X-Linked Retinitis Pigmentosa
Product Description
Mechanism of Action
R&D Progress
Applied Genetic Technologies Corporation - Pipeline Analysis
Applied Genetic Technologies Corporation - Pipeline Products by Target
Applied Genetic Technologies Corporation - Pipeline Products by Route of Administration
Applied Genetic Technologies Corporation - Pipeline Products by Molecule Type
Applied Genetic Technologies Corporation - Pipeline Products by Mechanism of Action
Applied Genetic Technologies Corporation - Recent Pipeline Updates
Applied Genetic Technologies Corporation - Dormant Projects
Applied Genetic Technologies Corporation - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Gene Therapy to Activate Retinal Pigment Epithelium 65 for Leber Congenital Amaurosis
Applied Genetic Technologies Corporation - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Applied Genetic Technologies Corporation, Key Information
Applied Genetic Technologies Corporation, Key Facts
Applied Genetic Technologies Corporation - Pipeline by Indication, 2015
Applied Genetic Technologies Corporation - Pipeline by Stage of Development, 2015
Applied Genetic Technologies Corporation - Monotherapy Products in Pipeline, 2015
Applied Genetic Technologies Corporation - Phase II, 2015
Applied Genetic Technologies Corporation - Phase I, 2015
Applied Genetic Technologies Corporation - Preclinical, 2015
Applied Genetic Technologies Corporation - Pipeline by Target, 2015
Applied Genetic Technologies Corporation - Pipeline by Route of Administration, 2015
Applied Genetic Technologies Corporation - Pipeline by Molecule Type, 2015
Applied Genetic Technologies Corporation - Pipeline Products by Mechanism of Action, 2015
Applied Genetic Technologies Corporation - Recent Pipeline Updates, 2015
Applied Genetic Technologies Corporation - Dormant Developmental Projects,2015
Applied Genetic Technologies Corporation - Discontinued Pipeline Products, 2015
List of Figures
Applied Genetic Technologies Corporation - Pipeline by Top 10 Indication, 2015
Applied Genetic Technologies Corporation - Pipeline by Stage of Development, 2015
Applied Genetic Technologies Corporation - Monotherapy Products in Pipeline, 2015
Applied Genetic Technologies Corporation - Pipeline by Top 10 Target, 2015
Applied Genetic Technologies Corporation - Pipeline by Top 10 Route of Administration, 2015
Applied Genetic Technologies Corporation - Pipeline by Top 10 Molecule Type, 2015
Applied Genetic Technologies Corporation - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report